Antimicrobial therapy for gastrointestinal diseases

Veterinary Clinics of North America - Equine Practice

Volumn 19, Issue 3, 2003, Pages 645-663

  Papich, Mark G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACITRACIN; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFTIOFUR; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; FLORFENICOL; GENTAMICIN; LINCOMYCIN; LINCOSAMIDE; MARBOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; ORBIFLOXACIN; OXYTETRACYCLINE; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; SULTAMICILLIN; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANOREXIA; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTEREMIA; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; COLIC; COLITIS; CORYNEBACTERIUM EQUI; DEPRESSION; DIARRHEA; DIPHTHERIA; DRUG BLOOD LEVEL; DRUG SAFETY; EHRLICHIA; EHRLICHIOSIS; ENTERITIS; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GASTROINTESTINAL DISEASE; HORSE; HUMAN; HYPERTHERMIA; INTESTINE MOTILITY; LAWSONIA; NEUROLOGIC DISEASE; NONHUMAN; RESPIRATORY DISTRESS; REVIEW; SALMONELLA; SALMONELLOSIS; SEPSIS; STRESS; VIRUS SHEDDING; VOMITING; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; CHEMICALLY INDUCED DISORDER; HORSE DISEASE; INTESTINE; INTESTINE ABSORPTION; KINETICS; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; CORYNEBACTERIUM; EHRLICHIA; ENTEROBACTER; EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI; RHODOCOCCUS EQUI; SALMONELLA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COLIC; DIARRHEA; DRUG RESISTANCE, BACTERIAL; GASTROINTESTINAL DISEASES; HORSE DISEASES; HORSES; INTESTINAL ABSORPTION; INTESTINES; KINETICS;

EID: 3242806756     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2003.08.009     Document Type: Review

References (72)

1. Cohen ND, Woods AM. Characteristics and risk factors for failure of horses with acute diarrhea to survive: 12 cases (1990-1996). J Am Vet Med Assoc 1999;214:382-6.
2. Magdesian KG, Hirsh DC, Jang SS, et al. Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1999). J Am Vet Med Assoc 2002;220:67-73.
3. Baker JR, Leyland A. Diarrhoea in the horse associated with stress and tetracycline therapy. Vet Rec 1973;93:583-4.
4. Cook WR. Diarrhea in the horse associated with stress and tetracycline therapy. Vet Rec 1973;93:15-7.
5. Bunch JE. Panel on the diarrhea problem in the horse. Proc Am Assoc Equine Pract 1960;6:81-92.
6. Schiefer HB. Equine colitis X; still an enigma? Can Vet J 1981;22:162-5.
7. White G, Prior SD. Comparative effects of oral administration of trimethoprim/sulphadiazine or oxytetracycline on the faecal flora of horses. Vet Rec 1982;111:316-8.
8. Moore Keir AA, Stampfli HR, Crawford J. Outbreak of acute colitis on a horse farm associated with tetracycline-contaminated sweet feed. Can Vet J 1999;40:718-20.
9. Wilson DA, MacFadden KE, Green EM, et al. Case control and historical cohort study of diarrhea associated with administration of trimethoprim- potentiated sulphonamides to horses and ponies. J Vet Intern Med 1996;10:258-64.
10. Indiveri MC, Hirsh DC. Tissues and exudates contain sufficient thymidine for growth of anaerobic bacteria in the presence of inhibitory levels of trimethoprim-sulfamethoxazole. Vet Microbiol 1992;32:235-42.
11. Lakritz J, Wilson WD, Marsh AE, Mihalyi JE. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. Am J Vet Res 2000;61:1011-5.
12. Lakritz J, Wilson WD, Marsh AE, Mihalyi JE. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am J Vet Res 2000;61:914-9.
13. Lakritz J, Wilson WD, Marsh AE, Mihalyi JE. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals. Vet Ther 2002;3:189-95.
14. Båverud V, Franklin A, Gunnarsson A, et al. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Vet J 1998;30:482-8.
15. Gustafsson A, Båverud V, Gunnarsson A, et al. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J 1997;29:314-8.
16. Stratton-Phelps M, Wilson WD, Gardner IA. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J Am Vet Med Assoc 2000;217:68-73.
17. Koenig JB, Cote N, LaMarre J, et al. Binding of radiolabeled porcine motilin and erythromycin lactobionate to smooth muscle membranes in various segments of the equine gastrointestinal tract. Am J Vet Res 2002;63:1545-50.
18. Stäempfli HR, Prescott JF, Brash ML. Lincomycin-induced severe colitis in ponies associated with Clostridium cadaveris. Can J Vet Res 1992;56:168-9.
19. Stäempfli HR, Prescott JF, Carman RJ, McCutcheon LJ. Use of bacitracin in the prevention and treatment of experimentally-induced idiopathic colitic in horses. Can J Vet Res 1992;56:233-6.
20. Raisbeck MF, Osweiler GD. Lincomycin-associated colitis in horses. J Am Vet Med Assoc 1981;179:362-3.
21. Thilsted JP, Newton WM, Crandell RA, Bevill RF. Fatal diarrhea in rabbits resulting from the feeding of antibiotic-contaminated feed. J Am Vet Med Assoc 1981;179:360-1.
22. Ensink JM, Klein WR, Mevius DJ, et al. Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin. J Vet Pharmacol Ther 1992;15:221-30.
23. Ensink JM, Vulto AG, van Miert ASJPAM, et al. Oral bioavailability and in vitro stability of pivampicillin, bacampicillin, talampicillin, and ampicillin in horses. Am J Vet Res 1996;57:1021-4.
24. Wilson WD, Spensley MS, Baggot JD, Hietala SK. Pharmacokinetics and estimated bioavailability of amoxicillin in mares, after intravenous, intramuscular, and oral administration. Am J Vet Res 1988;49:1688-93.
25. Wilson WD, Baggot JD, Adamson PJW, et al. Cefadroxil in the horse: pharmacokinetics and in vitro antibacterial activity. J Vet Pharmacol Ther 1985;8:246-53.
26. Baggot JD. Bioavailability and disposition kinetics of amoxicillin in neonatal foals. Equine Vet J 1988;20:125-7.
27. Duffee NE, Christensen JM, Craig AM. The pharmacokinetics of cefadroxil in the foal. J Vet Pharmacol Ther 1989;12:322-6.
28. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-40.
29. Gorbach SL. Antibiotics and Clostridium difficile. N Engl J Med 1999;341:1690-1.
30. Mahrt CR. Safety of ceftiofur sodium administered intramuscularly in horses. Am J Vet Res 1992;53:2201-5.
31. Freeman DE. Gastrointestinal pharmacology. Vet Clin North Am Equine Pract 1999;15:535-59.
32. McKellar QA, Varma KJ. Pharmacokinetics and tolerance of florfenicol in Equidae. Equine Vet J 1996;28:209-13.
33. Papich MG, Riviere JE. Fluoroquinolone antimicrobial drugs. In: Adams HR, editor. Veterinary pharmacology and therapeutics. 8th edition. Ames: Iowa State University Press; 2001. p. 898-917.
34. Gardner SY, Papich MG. Pharmacokinetics of moxifloxacin in adult horses. J Vet Pharmacol Ther; in press.
35. Hird DW, Casebolt DB, Carter JD, et al. Risk factors for salmonellosis in hospitalized horses. J Am Vet Med Assoc 1986;188:173-7.
36. Owen RR, Fullerton J, Barnum DA. Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. Am J Vet Res 1983;44:46-50.
37. Traub-Dargatz JL, Salman MD, Jones RL. Epidemiologic study of Salmonella shedding in the feces of horses and potential risk factors for development of the infection in hospitalized horses. J Am Vet Med Assoc 1990;196:1617-22.
38. Vivrette SL, Bostian A, Bermingham E, Papich MG. Quinolone-induced arthropathy in neonatal foals. Proc Am Assoc Equine Pract 2001;47:376-7.
39. Jones RL. Clostridial enterocolitis. Vet Clin North Am Equine Pract 2000;16:471-85.
40. Båverud V, Gustafsson A, Franklin A, et al. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997;29:279-84.
41. Jang SS, Hansen LM, Breher JE, et al. Antimicrobial susceptibility of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin Infect Dis 1997;25(Suppl 2):S266-7.
42. Sweeney RW, Sweeney CR, Weiher J. Clinical use of metronidazole in horses: 200 cases (1984-1989). J Am Vet Med Assoc 1991;198:1045-8.
43. Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 1992;33:1204-8.
44. Steinman A, Gips M, Lavy E, et al. Pharmacokinetics of metronidazole in horses after intravenous, rectal, and oral administration. J Vet Pharmacol Ther 2000;23:353-7.
45. Oluoch AO, Kim C-H, Weisiger RM, et al. Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998). J Am Vet Med Assoc 2001;218:381-4.
46. Orsini JA, Benson CE, Spencer PA, Van Miller E. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses. Am J Vet Res 1989;50:923-5.
47. Orsini JA, Spencer P. Epidemiology of aminoglycoside resistance in a large animal hospital. Equine Vet J 1997;29:319-21.
48. Geor RJ, Papich MG. Once-daily aminoglycoside dosing regimens. In: Robinson NE, editor. Current therapy in equine medicine. 5th edition. Philadelphia: WB Saunders; 2003. p. 850-3.
49. Tudor RA, Papich MG, Redding WR. Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery. J Am Vet Med Assoc 1999;15:503-6.
50. McFarlane D, Papich MG, Breuhaus B, et al. Pharmacokinetics of amikacin sulfate in sick and healthy foals [abstract]. In: Proceedings of the Fifth Conference of the International Veterinary Emergency and Critical Care Society. San Antonio: Veterinary Emergency and Critical Care Society; 1996.
51. Papich MG, Van Camp SD, Cole JA, Whitacre MD. Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after IV administration of enrofloxacin to mares. J Vet Pharmacol Ther 2002;25:1-8.
52. Walker RD. Fluoroquinolones. In: Prescott JF, Baggot JD, Walker RD, editors. Antimicrobial therapy in veterinary medicine. 3rd edition. Ames: Iowa State University Press; 2000. p. 315-38.
53. Giguère S, Sweeney RW, Bélanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996;57:1025-30.
54. Pyörälä S, Panu S, Kaartinen L. Single dose pharmacokinetics of enrofloxacin in horses. In: Proceedings of the European Association for Veterinary Pharmacology and Toxicology; 1994. p. 45-6.
55. Haines GR, Brown MP, Gronwall RR, et al. Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Can J Vet Res 2001;65:181-7.
56. Bousquet-Melou A, Bernard S, Schneider M, Toutain PL. Pharmacokinetics of marbofloxacin in horses. Equine Vet J 2002;34:366-72.
57. Carretero M, Rodríguez C, San Andrés MI, et al. Pharmacokinetics of marbo.oxacin in mature horses after single intravenous and intramuscular administration. Equine Vet J 2002;34:360-5.
58. Smith DGE, Lawson GHK. Lawsonia intracellularis: getting inside the pathogenesis of proliferative enteropathy. Vet Micrrobiol 2001;82:331-45.
59. Cooper DM, Gebhart CJ. Comparative aspects of proliferative enteritis. J Am Vet Med Assoc 1998;212:1446-51.
60. McOrist S, Mackie RA, Lawson GHK. Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy. J Clin Microbiol 1995;33:1314-7.
61. nd edition. NCCLS document M31-A2. Wayne, PA: NCCLS; 2002.
62. Schumacher J, Schumacher J, Rolsma M, et al. Surgical and medical treatment of an Arabian filly with proliferative enteropathy caused by Lawsonia intracellularis. J Vet Intern Med 2000;14:630-2.
63. Davis JL, Gardner SY, Jones SL, Schwabenton BA, Papich MG. Pharmacokinetics of azithromycin in foals after iv and oral dose and disposition into phagocytes. J Vet Pharmacol Ther 2002;25:99-104.
64. Madigan JE, Pusterla N. Ehrlichial diseases. Vet Clin North Am Equine Pract 2000;16:487-99.
65. Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial disease of small animals from the Infectious Disease Study Group of the ACVIM. J Vet Intern Med 2002;16:309-15.
66. Rikihisa Y, Jiang BM. Effect of antibiotics on clinical, pathologic and immunologic responses in murine Potomac horse fever: effects of doxycycline. Vet Microbiol 1989;19:253-62.
67. Bryant JE, Brown MP, Gronwall RR, Merritt KA. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine Vet J 2000;32:233-8.
68. Riond J-L, Duckett WM, Riviere JE, Jernigan AD, Spurlock SL. Concerned about intravenous use of doxycycline in horses [letter]. J Am Vet Med Assoc 1992;195:846-8.
69. Riond J-L, Riviere JE, Duckett WM, Atkins CE. Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies. Equine Vet J 1992;24:41-5.
70. Palmer JE, Benson CE. Effect of treatment with erythromycin and rifampin during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 1992;53:2071-6.
71. Palmer JE, Benson CE, Whitlock RH. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 1992;53:2300-4.
72. Palmer JE, Whitlock RH, Benson CE. Equine ehrlichial colitis: effect of oxytetracycline treatment during the incubation period of ehrlichial risticii infection in ponies. J Am Vet Med Assoc 1988;192:343-5.